ARTICLE | Company News
Cell Therapeutics seeking EMA approval of Pixuvri
November 2, 2010 12:23 AM UTC
Cell Therapeutics Inc. (NASDAQ:CTIC; Milan:CTIC) submitted an MAA to the European Medicines Agency for Pixuvri pixantrone as monotherapy to treat adult patients with relapsed or refractory aggressive ...